San Diego-based Element Biosciences, which is developing DNA sequencing technology, says it has raised $80M in a Series B funding round. The new funding came from Fidelity Management & Research Company and JS Capital LLC, along with Foresite Capital and Venrock. According to Element Biosciences, the new funds will go towards accelerating the development of its genomic sequencing products. The company has now raised more than $100M in total. Molly He, PhD is CEO and co-founder of Element.

Read more on OC Engine